In 2022, the AAP hosted an Addiction Treatment in Pediatric Settings ECHO (Extension for Community Healthcare Outcomes) to increase knowledge and capacity regarding treating substance use disorders in the medical home setting, with a focus on opioid use disorder for pediatric health care professionals.
*Please note: This curriculum was developed in reference to the buprenorphine waiver. As noted above, as of December 29, 2022, the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder is no longer required. These recordings DO NOT qualify for CME or MOC credit at this time.
This curriculum was developed using the ECHO (Extension for Community Healthcare Outcomes) modelTM. More information about Project ECHO may be found at www.aap.org/projectecho.
Session #1: Overview of Substance Use and Addiction in Adolescents
Duration: 8:14
Learning Objectives
- Review patterns of substance use among adolescents.
- Describe the neurobiological basis of addiction.
- Recognize the pediatric providers' role in prevention and treatment of adolescent substance use.
- List the key steps to becoming a waivered buprenorphine practitioner.
Session #2: Screening, Brief Intervention, and Referral to Treatment (SBIRT) Approaches
Duration: 19:53
Learning Objectives
- Use a validated screening tool to assess for adolescent substance use in a medical home setting.
- Recognize the signs and symptoms of mild, moderate, and severe substance use disorders (SUDs).
- Define and identify key steps of brief intervention (i.e., motivational interviewing) and referral to treatment.
Session #3: Cannabis and Nicotine Use Disorders
Duration: 15:29
Learning Objectives
- Review the pharmacologic effects of cannabis and nicotine.
- Describe modes of delivery for cannabis and nicotine, including e-cigarettes and vapes.
- List treatment strategies for cannabis and nicotine use disorders in the medical home setting, including use of medications.
Session #4: Alcohol Use Disorder
Duration: 15:26
Learning Objectives
- Review the pharmacologic effects of alcohol.
- List treatment strategies for alcohol use disorder (AUD) in the medical home setting, including use of medications.
Session #5: Treatment of Opioid Use Disorder part 1
Duration: 26:40
Learning Objectives
- Review the pharmacologic effects of opioids.
- Discuss medications for opioid use disorder.
- Describe the initiation of buprenorphine for adolescents.
Session #6:Treatment of Opioid Use Disorder part 2
Duration: 15:48
Learning Objectives
- Understand how to care for patients actively in withdrawal.
- Understanding how to care for patients not in withdrawal but experiencing cravings.
- Review strategies to reduce stigma in the medical home.
Session #7: Overdose Prevention and Other Medical Considerations
Duration: 25:13
Learning Objectives
- Review strategies to help prevent or reduce overdose risk.
- Identify the role of naloxone in treating opioid overdose.
- Recognize additional medical considerations in the treatment of opioid use disorder (eg, HIV, hepatitis C, sexually transmitted infections).
Session #8: Preparing Your Practice to Offer Medication to Treat Opioid Use Disorder
Duration: 26:43
Learning Objectives
- Discuss integrating medication for opioid use disorder care in the practice setting.
- Discuss workflow and confidentiality.
- Review coding and payment considerations.
Last Updated
07/29/2026
Source
American Academy of Pediatrics